Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in stage IV metastatic gallbladder cancer - Dr AVS Suresh - Video

Published On 2025-06-09T12:00:59+05:30 | Updated On 9 Jun 2025 2:39 PM IST

Overview

Chemotherapy-induced anemia (CIA) is a serious complication in cancer patients, impacting treatment continuity and quality of life. In this video, Dr. AVS Suresh, Senior Consultant Medical Oncologist and Hematologist at Continental Hospitals, Hyderabad, presents a real-world case of a 74-year-old woman with stage IV metastatic gallbladder cancer.

Through this case, he explores the clinical challenges and highlights the effective use of darbepoetin alfa (Cresp) in managing CIA. The video emphasizes how darbepoetin alfa helped improve and maintain hemoglobin levels, enhanced treatment tolerance, and supported uninterrupted cancer therapy.

This case study offers practical guidance for oncologists on integrating erythropoiesis-stimulating agents in routine cancer care.

Speakers

Dr AVS Suresh

Dr. AVS Suresh MBBS, MD, DM, PDCR. He is a Senior Consultant Medical Oncologist and Hematologist at Continental Hospitals, Gachibowli, Hyderabad. With over two decades of clinical experience, he has managed more than 5,000 hemato-oncology cases annually and is known for his expertise in treating both solid tumors—including breast, lung, gastrointestinal, and head & neck cancers—and hematologic malignancies such as leukemia, lymphoma, and multiple myeloma.